SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on its Phase 3 melanoma cancer-vaccine results and anticipation of fuller ESMO data, reinforced by CEO comments positioning the company as an mRNA platform spanning oncology and other diseases. Bulls point to the pipeline and momentum, while skeptics question the treatments broader efficacy, commercial scalability and valuation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys quarterly beat and raised full-year outlook, led by record QNX growth, are driving attention; traders are also focused on the QNX design wins involving Uber and Coretura. Bulls see momentum in automotive software and physical AI, while others question the muted, volatile post-earnings reaction and point to cautious near-term guidance and broader-market pressure.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos quarterly results beat expectations, but the shares barely moved as traders debated whether underlying sales momentum justifies the stocks premium valuation. Bulls pointed to resilient demand, while skeptics focused on the temporary tariff-refund benefit and questioned how earnings will look without it.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions reported achievement of 30 entangled logical qubits on its Sqale commercial quantum system, using 80 physical qubits, is driving attention as a significant quantum-computing milestone. Many traders view it as validation of the companys neutral-atom approach, while others say the stocks muted, choppy reaction and broader market conditions temper the excitement.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais multibillion-dollar, seven-year cloud-capacity agreement with Anthropic is driving attention, with traders viewing it as a major validation of its AI infrastructure business. Others are wary of the associated stock warrants and heavy buildout spending, and discuss profit-taking after the sharp after-hours surge.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondos launch of onchain investment portfolios using BlackRock-developed strategies is driving attention, reinforcing the RWA-tokenization and institutional-adoption narrative. Traders are largely bullish on the development, while some question whether the ONDO token itself will benefit without a fee or other value-accrual mechanism; others are taking profits after the sharp move.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Discussion centers on the jury outcome in Nektars breach-of-contract case against Eli Lilly, with traders citing a reported roughly $90 million judgment. Reactions are divided: some see it as a win, while others consider the award disappointing relative to expectations and question what the jurys decision means for the case.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solars steep selloff and fresh lows are being tied to analyst downgrades and limited visibility into near-term bookings, alongside solar-policy uncertainty and higher-rate concerns. Traders disagree on whether the move is an overreaction and buying opportunity or a sign of further weakness; some instead speculate about short-selling or China-related news without confirmation.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is drawing attention around Matrix-M pipeline developments, especially reported preclinical C. difficile vaccine results and manufacturing work as the company prepares for further development; traders are also discussing Sanofis H5N8 vaccine study. Many bulls speculate that oncology partnerships or other pipeline news could boost the stock or prompt short covering, while skeptics say those catalysts remain uncertain and criticize managements execution.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus is drawing attention after managements positive Medicare reimbursement outlook for its cancer-testing products and improving revenue expectations, fueling a sharp rally. Traders are also discussing heavy short interest and bullish options flow as potential momentum amplifiers, while others warn the move may be extended and point to valuation and insider-selling concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
